Top

European Radiology

Published in:

01-12-2019 | Prostate Cancer | Ultrasound

Shear-wave elastography: role in clinically significant prostate cancer with false-negative magnetic resonance imaging

Authors: Li-Hua Xiang, Yan Fang, Jing Wan, Guang Xu, Ming-Hua Yao, Shi-Si Ding, Hui Liu, Rong Wu

Published in: European Radiology | Issue 12/2019

Abstract

Objectives

To analyze the diagnostic value of adding SWE to MRI for the diagnosis of clinically significant prostate cancer with false-negative MRI results.

Methods

This was a retrospective study of 367 patients who underwent MRI, SWE, and prostate biopsy between March 2016 and November 2018 at the Shanghai Tenth People’s Hospital. Serum prostate-specific antigen (PSA) and free PSA (fPSA) were measured preoperatively. Diagnostic value and accuracy was determined for MRI alone and MRI + SWE using the receiver operator characteristic curve (ROC) analysis.

Results

MRI misdiagnosed 17.9% (21/117) clinically significant prostate cancers, including 15 lesions in the peripheral zone and 6 in the central zone. Both qualitative and quantitative SWE could help detect 66.7% (10/15) significant prostate cancers with false-negative MRI, but there was no association with the Gleason score (p > 0.05). When considering the sextant of the peripheral zone, a significant association was not seen with histopathology in qualitative SWE (p = 0.071) and quantitative SWE (p = 0.598). Among age, PSA, fPSA, volume of the prostate gland, fPSA/PSA, and PSAD, only PSAD (p = 0.019) was associated with SWE results in patients with negative MRI.

Conclusions

Adding SWE to MRI in patients with negative MRI for prostate examination could allow the correct diagnosis of additional patients and reduce the false-negative rate.

Key Points

• MRI plays an important role in clinically significant prostate cancers diagnosis.

• SWE plays an important role in clinically significant prostate cancers with negative MRI.

• Adding SWE to MRI in patients with negative MRI for prostate examination could allow the correct diagnosis of additional patients and reduce the false-negative rate.

Available only for authorised users

Leslie SW, Soon-Sutton TL, Siref LE (2017) Cancer, prostate. StatPearls. StatPearls Publishing, Treasure Island (2017) Cancer, prostate. StatPearls. StatPearls Publishing StatPearls Publishing LLC, Treasure Island

Zheng R, Zeng H, Zhang S, Chen W (2017) Estimates of cancer incidence and mortality in China, 2013. Chin J Cancer 36:66CrossRef

Wong MC, Goggins WB, Wang HH et al (2016) Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol 70:862–874CrossRef

Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2. Eur Urol 69:16–40

Borofsky S, George AK, Gaur S et al (2018) What are we missing? False-negative cancers at multiparametric MR imaging of the prostate. Radiology 286:186–195CrossRef

Correas JM, Tissier AM, Khairoune A et al (2015) Prostate cancer: diagnostic performance of real-time shear-wave elastography. Radiology 275:280–289CrossRef

Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2017) Shear-wave elastography for detection of prostate cancer: a systematic review and diagnostic meta-analysis. AJR Am J Roentgenol 209:806–814CrossRef

Sang L, Wang XM, Xu DY, Cai YF (2017) Accuracy of shear wave elastography for the diagnosis of prostate cancer: a meta-analysis. Sci Rep 7:1949CrossRef

Hamoen EHJ, de Rooij M, Witjes JA, Barentsz JO, Rovers MM (2015) Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol 67:1112–1121CrossRef

10.

Niu XK, Chen XH, Chen ZF, Chen L, Li J, Peng T (2018) Diagnostic performance of biparametric MRI for detection of prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol 211:369–378CrossRef

11.

Tan CH, Wei W, Johnson V, Kundra V (2012) Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 199:822–829CrossRef

12.

Su R, Xu G, Xiang L, Ding S, Wu R (2018) A novel scoring system for prediction of prostate cancer based on shear wave elastography and clinical parameters. Urology 121:112–117CrossRef

13.

Furlan A, Borhani AA, Westphalen AC (2018) Multiparametric MR imaging of the prostate: interpretation including Prostate Imaging Reporting and Data System version 2. Radiol Clin North Am 56:223–238CrossRef

14.

de Rooij M, Hamoen EH, Fütterer JJ, Barentsz JO, Rovers MM (2014) Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. AJR Am J Roentgenol 202:343–351CrossRef

15.

Mazaheri Y, Akin O, Hricak H (2017) Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: a review of current methods and applications. World J Radiol 9:416–425CrossRef

16.

Nazim SM, Ather MH, Salam B (2018) Role of multi-parametric (mp) MRI in prostate cancer. J Pak Med Assoc 68:98–104PubMed

17.

Abd-Alazeez M, Kirkham A, Ahmed HU et al (2014) Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard. Prostate Cancer Prostatic Dis 17:40–46CrossRef

18.

Benndorf M, Waibel L, Krönig M, Jilg CA, Langer M, Krauss T (2018) Peripheral zone lesions of intermediary risk in multiparametric prostate MRI: frequency and validation of the PI-RADSv2 risk stratification algorithm based on focal contrast enhancement. Eur J Radiol 99:62–67CrossRef

19.

Zuo MZ, Zhao WL, Wei CG et al (2017) Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer. Zhonghua Yi Xue Za Zhi 97:3693–3698PubMed

20.

Krishna S, McInnes M, Lim C et al (2017) Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the detection of peripheral zone Gleason score 3 + 4 = 7 cancers. AJR Am J Roentgenol 209:W365–w373CrossRef

21.

Becker AS, Cornelius A, Reiner CS et al (2017) Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer. Eur J Radiol 94:58–63CrossRef

22.

Polanec S, Helbich TH, Bickel H et al (2016) Head-to-head comparison of PI-RADS v2 and PI-RADS v1. Eur J Radiol 85:1125–1131CrossRef

23.

Futterer JJ, Briganti A, De Visschere P et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68:1045–1053CrossRef

24.

Thompson JE, van Leeuwen PJ, Moses D et al (2016) The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer. J Urol 195:1428–1435CrossRef

25.

Harvey H, Morgan V, Fromageau J, O’Shea T, Bamber J, deSouza NM (2018) Ultrasound shear wave elastography of the normal prostate: interobserver reproducibility and comparison with functional magnetic resonance tissue characteristics. Ultrason Imaging 161734618754487. https://doi.org/10.1177/0161734618754487 CrossRef

26.

Hoyt K, Castaneda B, Zhang M et al (2008) Tissue elasticity properties as biomarkers for prostate cancer. Cancer Biomark 4:213–225CrossRef

27.

Good DW, Stewart GD, Hammer S et al (2014) Elasticity as a biomarker for prostate cancer: a systematic review. BJU Int 113:523–534CrossRef

28.

Salomon G, Köllerman J, Thederan I et al (2008) Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol 54:1354–1362CrossRef

29.

Walz J, Marcy M, Pianna JT et al (2011) Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancer. World J Urol 29:589–594CrossRef

30.

Brock M, von Bodman C, Palisaar RJ et al (2012) The impact of real-time elastography guiding a systematic prostate biopsy to improve cancer detection rate: a prospective study of 353 patients. J Urol 187:2039–2043CrossRef

31.

Bercoff J, Tanter M, Fink M (2004) Supersonic shear imaging: a new technique for soft tissue elasticity mapping. IEEE Trans Ultrason Ferroelectr Freq Control 51:396–409CrossRef

32.

Barr RG, Memo R, Schaub CR (2012) Shear wave ultrasound elastography of the prostate: initial results. Ultrasound Q 28:13–20CrossRef

33.

Zhang M, Wang P, Yin B, Fei X, Xu XW, Song YS (2015) Transrectal shear wave elastography combined with transition zone biopsy for detecting prostate cancer. Zhonghua Nan Ke Xue 21:610–614PubMed

34.

Schouten MG, van der Leest M, Pokorny M et al (2017) Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-naive men? Eur Urol 71:896–903CrossRef

Title: Shear-wave elastography: role in clinically significant prostate cancer with false-negative magnetic resonance imaging
Authors: Li-Hua Xiang
Yan Fang
Jing Wan
Guang Xu
Ming-Hua Yao
Shi-Si Ding
Hui Liu
Rong Wu
Publication date: 01-12-2019
Publisher: Springer Berlin Heidelberg
Keywords: Prostate Cancer
Magnetic Resonance Imaging
Magnetic Resonance Imaging
Prostate Cancer
Published in: European Radiology / Issue 12/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-019-06274-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Shear-wave elastography: role in clinically significant prostate cancer with false-negative magnetic resonance imaging

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Please log in to get access to this content

Other articles of this Issue 12/2019

New predictors of aneurysm sac behavior after endovascular aortic aneurysm repair

Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique

Correction to: Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis

Correction to: Diagnostic performance of dual-energy CT and subtraction CT for renal lesion detection and characterization

Diagnosis of peripheral bone and prosthetic joint infections: overview on the consensus documents by the EANM, EBJIS, and ESR (with ESCMID endorsement)

Increased urinary bladder volume improves the detectability of urinary stones at the ureterovesical junction in non-enhanced computed tomography (NECT)